Dynavax Technologies Market Cap

Dynavax Technologies has a market cap or net worth of $1.60 billion as of November 21, 2024. Its market cap has decreased by -7.22% in one year.

Market Cap

1.60B

Enterprise Value

1.09B

1-Year Change

-7.22%

Ranking

#2150

Market Cap Chart

Since February 19, 2004, Dynavax Technologies's market cap has increased from $222.50M to $1.60B, an increase of 619.01%. That is a compound annual growth rate of 9.96%.

Market Cap History

Date	Market Cap	% Change
Nov 20, 2024	1.60B	-11.47%
Dec 29, 2023	1.81B	33.12%
Dec 30, 2022	1.36B	-19.57%
Dec 31, 2021	1.69B	244.22%
Dec 31, 2020	490.30M	2.21%
Dec 31, 2019	479.70M	-16.37%
Dec 31, 2018	573.60M	-49.38%
Dec 29, 2017	1.13B	644.48%
Dec 30, 2016	152.20M	-83.61%
Dec 31, 2015	928.40M	109.43%
Dec 31, 2014	443.30M	-13.87%
Dec 31, 2013	514.70M	1.06%
Dec 31, 2012	509.30M	20.97%
Dec 30, 2011	421.00M	13.85%
Dec 31, 2010	369.80M	531.06%
Dec 31, 2009	58.60M	74.93%
Dec 31, 2008	33.50M	-83.51%
Dec 31, 2007	203.20M	-41.66%
Dec 29, 2006	348.30M	177.97%
Dec 30, 2005	125.30M	-36.40%
Dec 31, 2004	197.00M	-11.46%
Feb 19, 2004	222.50M	-

View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Immunocore Holdings	1.63B
Nurix Therapeutics	1.61B
Viridian Therapeutics	1.60B
Neumora Therapeutics	1.59B
Certara	1.59B
Teladoc Health	1.54B
Travere Therapeutics	1.51B
Kiniksa Pharmaceuticals International,	1.50B

Market Cap Rankings